Treatment of Generalized Anxiety Disorder with Gabapentin
Joint Authors
Markota, Matej
Morgan, Robert J.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-12-14
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Gabapentin is frequently used in the treatment of anxiety disorders.
However, there are no randomized controlled trials on the effectiveness of this medication in generalized anxiety disorder (GAD), and there are only a few case reports.
We present a case of a 59-year-old female with a psychiatric history of GAD.
The patient discontinued benzodiazepines after more than 7 years of daily treatment which led to rebound anxiety, benzodiazepine withdrawal symptoms, and suicidal ideation.
She was psychiatrically hospitalized and started on gabapentin.
Over the next 10 months of outpatient follow-up, she attempted to taper off gabapentin due to personal preference to limit medications.
During this time, we observed a clear dose-response pattern of gabapentin on GAD symptoms.
In the absence of controlled studies, these findings may offer important information about the effectiveness of gabapentin in GAD.
American Psychological Association (APA)
Markota, Matej& Morgan, Robert J.. 2017. Treatment of Generalized Anxiety Disorder with Gabapentin. Case Reports in Psychiatry،Vol. 2017, no. 2017, pp.1-4.
https://search.emarefa.net/detail/BIM-1149609
Modern Language Association (MLA)
Markota, Matej& Morgan, Robert J.. Treatment of Generalized Anxiety Disorder with Gabapentin. Case Reports in Psychiatry No. 2017 (2017), pp.1-4.
https://search.emarefa.net/detail/BIM-1149609
American Medical Association (AMA)
Markota, Matej& Morgan, Robert J.. Treatment of Generalized Anxiety Disorder with Gabapentin. Case Reports in Psychiatry. 2017. Vol. 2017, no. 2017, pp.1-4.
https://search.emarefa.net/detail/BIM-1149609
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1149609